185 related articles for article (PubMed ID: 3006948)
1. Pathogenesis of hypercalcaemia of malignancy.
Mundy GR
Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
[TBL] [Abstract][Full Text] [Related]
2. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of humoral hypercalcaemia of malignancy.
Ralston SH
Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia of malignancy.
Jacobs JW; Simpson E
Adv Exp Med Biol; 1986; 208():357-66. PubMed ID: 3031945
[No Abstract] [Full Text] [Related]
5. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
Buchs B; Rizzoli R; Bonjour JP
Bone; 1991; 12(1):47-56. PubMed ID: 2054236
[TBL] [Abstract][Full Text] [Related]
7. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Ralston SH; Fogelman I; Gardiner MD; Boyle IT
Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
[TBL] [Abstract][Full Text] [Related]
8. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
9. Altered renal calcium handling in hypercalcemia of malignancy.
Tuttle KR; Kunau RT; Loveridge N; Mundy GR
J Am Soc Nephrol; 1991 Aug; 2(2):191-9. PubMed ID: 1954331
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcaemia of malignancy.
Kelly PJ; Eisman JA
Cancer Metastasis Rev; 1989 Jun; 8(1):23-52. PubMed ID: 2667784
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia of cancer: an update.
Goni MH; Tolis G
Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
[TBL] [Abstract][Full Text] [Related]
12. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ
N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302
[No Abstract] [Full Text] [Related]
13. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
[TBL] [Abstract][Full Text] [Related]
15. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
[TBL] [Abstract][Full Text] [Related]
16. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
[TBL] [Abstract][Full Text] [Related]
17. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Rosol TJ; Brooks CL; Capen CC
Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
[TBL] [Abstract][Full Text] [Related]
19. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
[TBL] [Abstract][Full Text] [Related]
20. Incidence and pathophysiology of hypercalcemia.
Mundy GR
Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
